Rituximab
Indication
Idiopathic thrombocytopenia purpura
Red
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Immune system and Malignant Disease
Background
Recommendation: Red (as an alternative 2nd line treatment in adults with ITP following failure of corticosteroid treatment or when corticosteroids and thrombopoietin receptor agonists are contraindicated)
Treatment requires initiation and continuation by specialist haematology services.
Recommendation
LSCMMG Recommendation:
Red
Reason for decision:
Specialist medicine
Supporting documents: